Home
Photo of Andrea Johansson Capusan

Andrea Johansson Capusan

Associate Professor, Docent

Publications

2024

Johan Nordgren, Bodil Monwell, Bjorn Johnson, Nina Veetnisha Gunnarsson, Andrea Johansson Capusan (2024) Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study Addiction science & clinical practice, Vol. 19, Article 25 Continue to DOI
Michal Pietrzak, Adam Yngve, Paul J. Hamilton, Anna Asratian, Emelie Gauffin, Andreas Löfberg, Sarah Gustavson, Emil Persson, Andrea Johansson Capusan, Lorenzo Leggio, Irene Perini, Gustav Tinghög, Markus Heilig, Rebecca Böhme (2024) Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial Neuropsychopharmacology Continue to DOI
Björn Johnson, Bodil Monwell, Andrea Johansson Capusan (2024) Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study Harm Reduction Journal, Vol. 21, Article 68 Continue to DOI

2023

Irene Perini, Leah M. Mayo, Andrea Johansson Capusan, Elisabeth Paul, Adam Yngve, Robin Kämpe, Emelie Gauffin, Raegan Mary Rose Mazurka, Bijar Ghafouri, Niclas Stensson, Anna Asratian, J. Paul Hamilton, Åsa Kastbom, Per A Gustafsson, Markus Heilig (2023) Resilience to substance use disorder following childhood maltreatment: association with peripheral biomarkers of endocannabinoid function and neural indices of emotion regulation Molecular Psychiatry, Vol. 6, p. 2563-2571 Continue to DOI
Michal Pietrzak, Adam Yngve, Paul Hamilton, Robin Kämpe, Rebecca Böhme, Anna Asratian, Emelie Gauffin, Andreas Löfberg, Sarah Gustavsson, Emil Persson, Andrea Johansson Capusan, Lorenzo Leggio, Irene Perini, Gustav Tinghög, Markus Heilig (2023) A randomized controlled experimental medicine study of ghrelin in value-based decision making Journal of Clinical Investigation, Vol. 133, Article e168260 Continue to DOI

Research

A photo montage of some people partying, a homeless person and a therapy session.

The Johansson Capusan Lab

We explore genetic and environmental risk and follow clinical outcomes in addiction medicine using national and regional Swedish registers with the overall aim to improve healthcare for addiction.

News

News from external sources

2023

Depot Medication: A Game-Changer in Opioid Addiction Treatment
4 December, 2023, BNN Breaking

Research links childhood trauma with addictions later in life (in Swedish)
10 August, 2023, Socionomen.se

Nordic Drug's Big Price 2023 (in Swedish)
12 June, 2023, Mynewsdesk press release

2022

Systembolaget grants SEK 10 million for alcohol research for 2023 (in Swedish)
12 December, 2022, Cision press release

The dark side – ADHD common in substance use and criminality (in Swedish)
21 February, 2022 , Läkartidningen

News from LiU

Genes play a major role in substance abuse in ADHD

It is principally hereditary factors that lie behind adults with ADHD often developing alcohol dependence and binge eating. This is the conclusion of a doctoral thesis from Linköping University.

Organisation

Center for Social and Affective Neuroscience - CSAN

Center for Social and Affective Neuroscience (CSAN) integrates knowledge and methodology from different areas of basic and clinical neuroscience.

Department of Biomedical and Clinical Sciences (BKV)

What characterizes the Department of Biomedical and Clinical Sciences (BKV) is the wide breadth of research and education. BKV is one of the largest departments at LiU with affiliation mainly to the Faculty of Medicine and Health Sciences.

Tags